Epidemiologic Characteristics Determining the Choice of Direct-Acting Antiviral Therapy in HCV Patients: An Italian Real-World Evidence Study

Pangenotypic direct-acting antivirals (pDAAs) have transformed hepatitis C virus (HCV) treatment. In Italy, sofosbuvir/velpatasvir (SOF/VEL) and glecaprevir/pibrentasvir (GLE/PIB) are available. While both show similar efficacy, differences in patient profiles and potential drug–drug interactions (D...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Nicola Pugliese, Fabio Conti, Valerio Rosato, Paolo Gallo, Stefano Gitto, Marco Riglietta, Francesca Frigerio, Valentina Perrone, Chiara Veronesi, Maria Cappuccilli, Luca Degli Esposti, Alessandra Mangia, Loreta A. Kondili
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	MDPI AG 2025-11-01
Reeks:	Pathogens
Onderwerpen:	drug–drug interactions (DDIs) glecaprevir/pibrentasvir hepatitis C virus (HCV) pangenotypic direct-acting antivirals sofosbuvir/velpatasvir
Online toegang:	https://www.mdpi.com/2076-0817/14/11/1177
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!